Massive rhabdomyolysis and life threatening hyperkalaemia in a patient with the combination of cerivastatin and gemfibrozil.
Hendriks
F
F
Department of Internal Medicine, Horacio Oduber Ziekenhuis, Aruba, The Netherlands.
Kooman
J P
JP
van der Sande
F M
FM
D000368:Aged; D002637:Chest Pain / Q000139:chemically induced / Q000175:diagnosis; D004338:Drug Combinations; D004562:Electrocardiography; D005260:Female; D015248:Gemfibrozil / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006947:Hyperkalemia / Q000139:chemically induced* / Q000628:therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D018482:Muscle, Skeletal / Q000187:drug effects; D010146:Pain / Q000139:chemically induced; D011725:Pyridines / Q000009:adverse effects*; D006435:Renal Dialysis; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000628:therapy
D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil